72% Of The 2009 Dividend Will Be Reinvested

Date: 2 July 2010
Source: Saint-Gobain Glass
Saint-Gobain shareholders responded favorably to the dividend reinvestment option, with 72.1% of the total dividend to be paid in stock.

This high reinvestment rate, which attests to shareholders’ confidence in the Group’s strategy and long-term growth outlook, allows Saint-Gobain to strengthen its equity by €368 million.
A total of 12.9 million new shares will be issued, equivalent to 2.5% of outstanding shares. The new shares will be issued and delivered on July 2. They will carry rights to the 2010 dividend and will rank pari passu to existing shares from the issue date. An application will be made for the new shares to be listed on NYSE Euronext Paris on July 2.
The share issue will have the effect of increasing Compagnie de Saint-Gobain’s share capital as of June 30 to €2,123 million, represented by 530.8 million ordinary shares with a par value of €4 each, all fully paid and all in the same class. Cash dividends will also be paid on July 2, for a total of €141.8 million. During the Annual General Meeting of June 3, Saint-Gobain shareholders approved payment of a 2009 dividend of €1 per share and the option to receive the dividend in cash or in Saint-Gobain shares issued at a price of €28.58 per share. Shareholders that chose the stock dividend alternative were required to notify the Company between June 9 and June 23.

600450 72% Of The 2009 Dividend Will Be Reinvested glassonweb.com

See more news about:

Others also read

A bright future is ahead for glass, thanks to a serious focus on innovation, the environment, and sustainability, the industry’s annual prestige awards ceremony at the Millennium Gallery in Sheffield heard. (Thurs 22 November).
Let’s re-live the event highlights together.
Saint-Gobain has approved the most important operation planned in Europe, which will be carried out over the next two years.
The façade of the RAL building in Bonn unmistakeably showcases the identity of the client and user of the building.
Glassolutions’ Installation business has relaunched as Facades & Glazing Solutions UK Ltd (FGS) following its sale to private investment firm CoBe Capital.
SUPERCONTRYX - a lead glass should be an extremely important element of your medical facility’s X-ray protection strategy as it attenuates the effect of radiations significantly.

Add new comment